Beximco Pharmaceuticals Limited, a fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, has commenced the export of pharmaceuticals to Kuwait. This marks the first time a Bangladeshi pharmaceutical company has launched pharmaceutical products in any Gulf member country under the Gulf Cooperation Council (GCC).
10 Jul 2016
Managing Director of Beximco Pharma, Nazmul Hassan MP, commented:
“Beximco Pharma continues to build its presence in emerging and developed markets. The Company is increasingly focused on regulated markets, such as the US, EU, GCC and Australia, where the demand for generic pharmaceutical products is rising. The Gulf market is an important market for us and the launch of our products in Kuwait will open up new opportunities in the region. We will continue to expand our product range in the Gulf market, providing patients with safe and affordable treatment options.”